miR548ai antagonism attenuates exosome-induced endothelial cell dysfunction is a research paper published in Cell Death Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Grant: HL-143469
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Grant: HL-129785
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Grant: HL-133665
NHLBI NIH HHS
Grant: R01 HL143469
NHLBI NIH HHS
Grant: R01 HL129785
NHLBI NIH HHS
Grant: R01 HL133665
National Institutes of Health
Grant: 5R01HL143469-03
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery
National Institutes of Health
Grant: 5R01HL129785-03
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction
National Institutes of Health
Grant: 5R01HL133665-03
BET Bromodomain proteins as Novel Epigenetic Targets for prevention of Intimal Hyperplasia after Vascular Surgery
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
FWCI
0.30
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords